AIOMEGA’s AIO Breathe®: First prescribed clinical use of an FDA-cleared mandibular repositioning device in pediatric OSA
AIOMEGA® announced the first prescribed clinical use of AIO BREATHE® mandibular repositioning device, FDA-cleared for pediatric obstructive sleep apnea (OSA). TYLER, TX, UNITED STATES, February 3, 2026 /EINPresswire.com/ -- AIOMEGA® today …